Table 2 Vaginal colonization with antimicrobial drug-resistant potentially pathogenic gram-positive bacteria among study women in labor
Antibioticsa | Number of the 1472 study women who were colonized with bacteria resistant to one or more antibiotics (prevalence of colonization /proportion of isolates, in %) | |||
|---|---|---|---|---|
Enterococcus spp. (n = 47/47)c | S. aureus (n = 117/121) | Group A Streptococcus (n = 3/3) | Group B Streptococcus (n = 3/3) | |
Trimethoprim-Sulfamethoxazole | NA | 77 (5.2/63.6) | 2 (0.1/66.7) | 1 (0.1/33.3) |
Ciprofloxacin | 40 (2.7/85.1) | 48 (3.3/39.7) | NA | NA |
Chloramphenicol | 19 (1.3/40.4) | 26 (1.8/21.5) | 0 [6] | 1 (0.1/33.3) |
Gentamicin | NA | 38 (2.6/31.4) | NA | NA |
Penicillin | 18 (1.2/38.3) | 93 (6.3/76.9) | 0 [6] | 1 (0.1/33.3) |
Ampicillin | NA | NA | NA | 1 (0.1/33.3) |
Tetracycline | 30 (2.0/63.8) | 70 (4.8/57.9) | 3 (0.2/100) | 3 (0.2/100) |
Erythromycin | 30 (2.0/63.8) | 89 (6.0/73.6) | 2 (0.1/66.7) | 3 (0.2/100) |
Vancomycin | 6 (0.4/12.8) | 6 (0.4/5.0) | 1 (0.1/33.3) | 1 (0.1/33.3) |
Ceftriaxone | NA | NA | 0 [6] | 0 [6] |
Linezolid | 8 (0.5/17.0) | NA | NA | NA |
Oxacillin | 37 (2.5/78.7) | 85 (5.8/70.2) | 1 (0.1/33.3) | 1 (0.1/33.3) |
MRSA | NA | 85 (5.8/70.2) | NA | NA |
VRSA/VRE | 6 (0.4/12.8) | 6 (0.4/5.0) | NA | NA |
iMLSB-resistant S. aureus | NA | 18 (1.2/14.9) | NA | NA |
cMLSB-resistant S. aureus | NA | 24 (1.6/19.8) | NA | NA |
MDR | 37 (2.5/78.7) | 85 (5.8/70.2) | 1 (0.1/33.3) | 1 (0.1/33.3) |
MDRb | 31 (2.1/66.0) | 0 [6] | 1 (0.1/33.3) | 1 (0.1/33.3) |